CliniSense is a new startup
corporation, located in Silicon Valley, California. The company is focused
on developing improved technology for stability and shelf-life monitoring.
Although we are primarily focused on the biotechnology,
defense, and medical fields, our technology is general purpose, and we
welcome customers from any area.
We have much
experience with biochemistry, medical instrumentation, software design, and
FDA regulations. In addition to licensing LifeTrack IP, we provide a
range of consulting services designed to get you up and running as quickly
as possible. These services include:
Help with FMEA
the best stability model for your application
embedded software design
Help design and
implement suitable V&V experiments
regulatory interaction and submissions
We will be happy to visit your
company and give presentations and demonstrations. However since we are
a new startup, we need to focus our resources and energy on the most
interested potential customers. Thus our policy is to request
reimbursement for travel expenses. This helps us distinguish high
interest from casual interest.
CliniSense, Corp., 15466 Los Gatos Blvd., Suite 109-355, Los Gatos, CA
Telephone: (408) 348-1495 Fax: (408) 399-9705 Email:
Founder and CEO:
Stephen E. Zweig, Ph.D.
Dr. Zweig has over twenty years experience in
biotechnology. He founded Avocet Medical, Inc. in 1991, served as
CEO through 1997, and Chairman through 2001. Avocet developed the AvoSureTM home CoumadinTM monitoring meter, which
pioneered new treatments for thrombosis in the US and Europe. Its
innovative dry-reagent protease-substrate chemistry and miniaturized
fluorescent detector technology won an AAMI award in 1997, and has recently
been acquired by Beckman-Coulter.
Dr. Zweig received his Ph.D. in biochemistry from UCSD in
1980. He was an assistant professor in pharmacology at Baylor College
of Medicine, and an Arthritis Foundation postdoctoral fellow at NIH.
Dr. Zweig has also held management positions at Bayer Diagnostics, and LifeScan, a Johnson
and Johnson company.
Dr. Zweig is an advisor to the College of Creative Studies